Vasoactive intestinal peptide gene polymorphisms, associated with its serum levels, predict treatment requirements in early rheumatoid arthritis

We previously reported that early arthritis (EA) patients with low vasoactive intestinal peptide (VIP) serum levels demonstrate a worse clinical disease course. In this study, we analysed whether variants in the VIP gene correlated with its serum levels and clinical EA parameters. The VIP gene was s...

Descripción completa

Detalles Bibliográficos
Autores principales: Seoane, Iria V., Martínez, Carmen, García-Vicuña, Rosario, Ortiz, Ana M., Juarranz, Yasmina, Talayero, Vanessa C., González-Álvaro, Isidoro, Gomariz, Rosa P., Lamana, Amalia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5794878/
https://www.ncbi.nlm.nih.gov/pubmed/29391448
http://dx.doi.org/10.1038/s41598-018-20400-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5794878/
https://www.ncbi.nlm.nih.gov/pubmed/29391448
http://dx.doi.org/10.1038/s41598-018-20400-6

Ejemplares similares